neoplasm
• at 32 weeks after N-nitrosodiethylamine (DEN) injection, mice developaggressive hepatocellular carcinoma, with tumorigenesis affecting the entire liver, with elevated serum aspartate transaminase, alanine transaminase, and total protein levels compared to wild-type mice which have either no nodules or very small nodules
|
• at 1 year of age, 42% of mice develop hepatic nodules that are hepatocellular carcinoma, with loss of hepatic architecture
• maker analysis indicates the expansion of tumor-initiation cells in livers
|
liver/biliary system
• mice exhibit chronic inflammation as indicated by increased expression of IL6 and TNFalpha and increased infiltration of macrophages in tumor bearing livers
|
• at 1 year of age, 42% of mice develop hepatic nodules that are hepatocellular carcinoma, with loss of hepatic architecture
• maker analysis indicates the expansion of tumor-initiation cells in livers
|
• in a sphere formation assay, hepatocytes form robust spheres that gradually increase in size and number, indicating an expansion of tumor-initiation cells compared to wild-type hepatocytes which form small spheres
• hepatocytes show invasion through Matrigel that is not seen in wild-type hepatocytes
|
immune system
• mice exhibit chronic inflammation as indicated by increased expression of IL6 and TNFalpha and increased infiltration of macrophages in tumor bearing livers
|
homeostasis/metabolism
• at 32 weeks after N-nitrosodiethylamine (DEN) injection, mice developaggressive hepatocellular carcinoma, with tumorigenesis affecting the entire liver, with elevated serum aspartate transaminase, alanine transaminase, and total protein levels compared to wild-type mice which have either no nodules or very small nodules
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
hepatocellular carcinoma | DOID:684 |
OMIM:114550 |
J:242582 |